Value of in vivo T2 measurement for myocardial fibrosis assessment in diabetic mice at 11.75 T

Investigative Radiology

Volumn 47, Issue 5, 2012, Pages 319-323

  Bun, Sok Sithikun ^a,b   Kober, Frank ^a   Jacquier, Alexis ^a   Espinosa, Leon ^c   Kalifa, Jérôme ^a   Bonzi, Marie France ^d   Kopp, Francis ^d   Lalevee, Nathalie ^e   Zaffran, Stephane ^d   Deharo, Jean Claude ^b   Cozzone, Patrick J ^a   Bernard, Monique ^a  

^a University of Aix Marseille   (France)

^b TIMONE HOSPITAL   (France)

^c AIX MARSEILLE UNIVERSITÉ   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

^e AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

arrhythmias; diabetes; fibrosis; MRI; myocardium; T2

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIAGNOSTIC VALUE; EXTRACELLULAR MATRIX; HEART MUSCLE FIBROSIS; HEART VENTRICLE TACHYCARDIA; HISTOPATHOLOGY; IN VIVO STUDY; MAGNETIC FIELD; MALE; MICROCIRCULATION; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; STREPTOZOCIN DIABETES;

EID: 84859912970     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e318243e062     Document Type: Article

References (30)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782-787. (Pubitemid 34000780)
2. Trost S, LeWinter M. Diabetic cardiomyopathy. Curr Treat Options Cardiovasc Med. 2001;3:481-492.
3. Francis GS. Diabetic cardiomyopathy: fact or fiction? Heart. 2001;85:247-248. (Pubitemid 32973546)
4. Hayat SA. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond). 2004;107:539-557. (Pubitemid 39627201)
5. Beltrami CA, Finato N, Rocco M, et al. The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol. 1995;27:291-305.
6. Kanoupakis EM, Manios EG, Kallergis EM, et al. Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment. J Am Coll Cardiol. 2010;55:2753-2759.
7. Zannad F, Rossignol P, Iraqi W. Extracellular matrix fibrotic markers in heart failure. Heart Fail Rev. 2010;15:319-329.
8. Weber KT, Janicki JS, Shroff SG, et al. Collagen remodeling of the pressureoverloaded, hypertrophied nonhuman primate myocardium. Circ Res. 1988; 62:757-765.
9. Bohl S, Lygate CA, Barnes H, et al. Advanced methods for quantification of infarct size in mice using three-dimensional high-field late gadolinium enhancement MRI. Am J Physiol Heart Circ Physiol. 2009;296:H1200-H1208.
10. Maya L, Villarreal FJ. Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis. J Mol Cell Cardiol. 2010;48:524-529.
11. Iles L, Pfluger H, Phrommintikul A, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008;52:1574-1580.
12. Loganathan R, Bilgen M, Al-Hafez B, et al. Characterization of alterations in diabetic myocardial tissue using high resolution MRI. Int J Cardiovasc Imaging. 2006;22:81-90. (Pubitemid 43372356)
13. Schneider J, Cassidy P, Lygate C, et al. Fast, high-resolution in vivo cine magnetic resonance imaging in normal and failing mouse hearts on a vertical 11.7 T system. J Magn Reson Imaging. 2003;18:691-701. (Pubitemid 37467270)
14. Parisi A, Moynihan P, Feldman C, et al. Approaches to determination of left ventricular volume and ejection fraction by real-time two-dimensional echocardiography. Clin Cardiol. 1979;2:257-263. (Pubitemid 9253847)
15. Gudbjartsson H, Patz S. The Rician distribution of noisy MRI data. Magn Reson Med. 1995;34:910-914.
16. Berul CI, Aronovitz MJ, Wang PJ, et al. In vivo cardiac electrophysiology studies in the mouse. Circulation. 1996;94:2641-2648. (Pubitemid 26403597)
17. Maguire CT, Bevilacqua LM, Wakimoto H, et al. Maturational atrioventricular nodal physiology in the mouse. J Cardiovasc Electrophysiol. 2000;11: 557-564. (Pubitemid 30304808)
18. Kitamura M, Shimizu M, Kita Y, et al. Quantitative evaluation of the rate of myocardial interstitial fibrosis using a personal computer. Jpn Circ J. 1997; 61:781-786.
19. Cameron IL, Ord VA, Fullerton GD. Characterization of proton NMR relaxation times in normal and pathological tissues by correlation with other tissue parameters. Magn Reson Imaging. 1984;2:97-106. (Pubitemid 14050412)
20. Beyers RJ, Smith RS, Xu Y, et al. T(2)-weighted MRI of post-infarct myocardial edema in mice. Magn Reson Med. 2012;67:201-209.
21. Tilak GS, Hsu LY, Hoyt RF, et al. In vivo T2-weighted magnetic resonance imaging can accurately determine the ischemic area at risk for 2-day-old non reperfused myocardial infarction. Invest Radiol. 2008;43:7-15.
22. Sparrow P, Messroghli DR, Reid S, et al. Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study. Am J Roentgenol. 2006;187:630-635.
23. Iltis I, Kober F, Cozzone PJ, et al. Noninvasive characterization of myocardial blood flow in diabetic, hypertensive, and diabetic-hypertensive rats using spin-labeling MRI. Microcirculation. 2005;12:607-614. (Pubitemid 43023804)
24. Basu R, Oudit GY, Wang X, et al. Type I diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function. Am J Physiol Heart Circ Physiol. 2009;297:H2096-H2108.
25. Mahgoub MA, Abd-Elfattah AS. Diabetes mellitus and cardiac function. Mol Cell Biochem. 1998;180:59-64. (Pubitemid 28118804)
26. Tomaselli GF, Beuckelmann DJ, Calkins HG, et al. Sudden cardiac death in heart failure. The role of abnormal repolarization. Circulation. 1994;90: 2534-2539. (Pubitemid 24354344)
27. Jourdon P, Feuvray D. Calcium and potassium currents in ventricular myocytes isolated from diabetic rats. J Physiol. 1993;470:411-429. (Pubitemid 23322497)
28. Pogwizd SM, McKenzie JP, Cain ME, et al. Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Circulation. 1998;98:2404-2414. (Pubitemid 28549784)
29. Lin H, Ogawa K, Imanaga I, et al. Alterations of connexin 43 in the diabetic rat heart. Adv Cardiol 2006:243-254. (Pubitemid 43805868)
30. Sato T, Ohkusa T, Honjo H, et al. Altered expression of connexin 43 contributes to the arrhythmogenic substrate during the development of heart failure in cardiomyopathic hamster. Am J Physiol Heart Circ Physiol. 2008;294:1164-1173.